7″ Olivercrona (Crafoord) Artery Clamp
Product Overview
The 7″ Olivercrona (Crafoord) Artery Clamp is a precision surgical instrument designed for vascular and cardiovascular procedures. Key features include:
✔ Optimal vessel occlusion – Ensures secure clamping without slippage.
✔ Durable construction – Made from high-grade stainless steel for longevity.
✔ Ergonomic design – Provides a comfortable grip for surgeons during lengthy procedures.
Key Specifications
-
Length: 7 inches (178 mm)
-
Material: High-quality German stainless steel (AISI 410/420)
-
Finish: Highly polished, corrosion-resistant
-
Type: Non-traumatic, atraumatic jaw design
-
Application: Vascular, cardiovascular, and general surgery
-
Sterilization: Autoclavable (up to 135°C)
Product Description Table
| Attribute | Details |
|---|---|
| Model | Olivercrona (Crafoord) Artery Clamp |
| Size | 7 inches (178 mm) |
| Jaw Type | Atraumatic, serrated |
| Handle Design | Ring handles with secure locking mechanism |
| Material Grade | Premium German stainless steel |
| Weight | ~50 grams (varies slightly by batch) |
| Reusable | Yes (autoclavable) |
| Certification | ISO 13485, CE marked |
| Packaging | Individually packed in sterile peel pouch (optional bulk packaging) |
Additional Information
-
Precision Engineering: Designed for delicate vascular procedures to minimize tissue trauma.
-
Versatile Use: Ideal for cardiac, thoracic, and neurosurgical applications.
-
Reliable Performance: Trusted by surgeons worldwide for secure vessel occlusion.
-
Customization: Available in different sizes upon request (e.g., 5.5″, 6″, 8″).
Why Choose Surg Tools?
✔ Premium Quality – Surgical-grade stainless steel for durability.
✔ Trusted by Professionals – Used in leading hospitals and surgical centers.
✔ Global Shipping – Fast and reliable delivery options.
Enhance your surgical toolkit with the 7″ Olivercrona (Crafoord) Artery Clamp – a must-have for vascular and cardiovascular procedures.
Order now or contact us for bulk inquiries!








Reviews
There are no reviews yet.